Frailty and all-cause and cause-specific mortality in Japan. (April 2023)

• Record Type: Journal Article
• Authors: Matsuo, Rumi; Matsumoto, Naomi; Mitsuhashi, Toshiharu; Takao, Soshi; Yorifuji, Takashi
• Is Part Of: Archives of gerontology and geriatrics. Volume 107(2023)
• Publication Date: 2023-04
• Subjects: Frailty -- Prefrailty -- Kihon Checklist -- Cardiovascular disease -- Respiratory disease -- Cancer; CI confidence interval -- CVD cardiovascular disease -- HR hazard ratio -- KCL Kihon Checklist; Aging -- Periodicals; Geriatrics -- Periodicals; Gerontology -- Periodicals; Electronic journals; 305.26
• DOI: 10.1016/j.archger.2022.104906
• Languages: English
• ISSNs: 0167-4943

Abstract

Highlights: We analyzed 43, 312 participants aged ≥ 65 years in Okayama City, Japan. We used the Kihon Checklist (KCL) to assess frailty. Prefrailty and frailty can increase the risk of all-cause mortality. A similar pattern was observed for cardiovascular disease, respiratory disease, and cancer mortality. Younger people and women tended to have higher effect estimates than older people and men. Abstract: Background: In aging societies, there is an increasing focus on the concept of frailty. However, there is no consistent means to assess this concept. We assessed frailty using the Kihon Checklist (KCL), which is widely used in Japan, and examined the association between frailty and all-cause and cause-specific mortality in Japan, the most aged society in the world. Methods: This was a retrospective cohort study, and we analyzed 43, 312 participants aged ≥ 65 years who were enrolled in basic health checkups in Okayama City, Japan. We defined the frailty status of the participants using the KCL. To assess the association of frailty status with all-cause and cause-specific mortality, we used cause-specific Cox proportional hazard models to estimate hazard ratios (HRs), adjusting for individual potential confounders. Mean follow-up time was 9.3 years. Results: The fully adjusted HR for all-cause mortality was 1.34 (95% confidence interval [CI]: 1.27-1.41) for the prefrail group and 2.22 (95% CI: 2.11-2.33) for the frail group. A similar pattern was observed for cardiovascular disease, respiratory disease, and cancer mortality. Younger people (65–74 years) and women tended to have higher effect estimates than older people (≥ 75 years) and men. Conclusion: Prefrailty and frailty can increase the risk of both all-cause and cause-specific mortality. Our study suggests that to support frail patients, it could be effective to focus on the prevention and management of cardiovascular and respiratory disease, and that the KCL may be useful as a method of screening for frailty.